Esperion Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:0ET Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
17 Apr 25	Sell€93	Eric Warren	Individual	108	€0.86
17 Apr 25	Sell€7	Benjamin Halladay	Individual	8	€0.85
18 Mar 25	Sell€3,309	Eric Warren	Individual	2,433	€1.36
18 Mar 25	Sell€4,795	Benjamin Halladay	Individual	3,535	€1.36
18 Mar 25	Sell€17,949	Sheldon Koenig	Individual	13,047	€1.38
19 Feb 25	Sell€20	Benjamin Halladay	Individual	11	€1.79
19 Feb 25	Sell€429	Eric Warren	Individual	239	€1.79
17 Jan 25	Sell€270	Eric Warren	Individual	123	€2.20
17 Jan 25	Sell€20	Benjamin Halladay	Individual	9	€2.20
17 Dec 24	Sell€5,169	Eric Warren	Individual	2,234	€2.31
17 Dec 24	Sell€7,492	Benjamin Halladay	Individual	3,245	€2.31
17 Dec 24	Sell€29,236	Sheldon Koenig	Individual	12,447	€2.35
19 Nov 24	Sell€403	Eric Warren	Individual	197	€2.04
17 Oct 24	Sell€209	Eric Warren	Individual	107	€1.96
17 Sep 24	Sell€4,183	Eric Warren	Individual	2,608	€1.60
17 Sep 24	Sell€23,506	Sheldon Koenig	Individual	14,550	€1.62
19 Aug 24	Sell€371	Eric Warren	Individual	211	€1.76
17 Jul 24	Sell€2,180	JoAnne Foody	Individual	917	€2.38
17 Jul 24	Sell€256	Eric Warren	Individual	108	€2.37
18 Jun 24	Sell€6,754	Eric Warren	Individual	2,540	€2.66
18 Jun 24	Sell€8,769	JoAnne Foody	Individual	3,285	€2.67

Insider Trading Volume

Insider Buying: 0ET insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of 0ET?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	1,553,611	0.784%
General Public	79,099,677	39.9%
Institutions	117,546,174	59.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 51.77% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
7.31%	BlackRock, Inc.	14,493,020	€10.3m	1.81%	no data
5.8%	The Vanguard Group, Inc.	11,487,729	€8.2m	-1.95%	no data
5.52%	Wasatch Advisors LP	10,931,257	€7.8m	-55.4%	0.03%
4.89%	Bellevue Asset Management AG	9,694,064	€6.9m	-2.51%	0.12%
3.5%	Two Seas Capital LP	6,930,871	€4.9m	11.2%	0.75%
3.25%	Morgan Stanley, Investment Banking and Brokerage Investments	6,435,354	€4.6m	4.4%	no data
2.29%	State Street Global Advisors, Inc.	4,548,248	€3.2m	0.98%	no data
2.24%	Geode Capital Management, LLC	4,446,297	€3.2m	2.45%	no data
1.91%	Meditor Group Ltd.	3,791,300	€2.7m	0%	1.66%
1.83%	Marshall Wace LLP	3,632,958	€2.6m	0%	no data
1.57%	Teachers Insurance and Annuity Association-College Retirement Equities Fund	3,110,603	€2.2m	0%	no data
1.51%	Indaba Capital Management, L.P.	3,000,000	€2.1m	0%	3.77%
1.38%	Two Sigma Investments, LP	2,731,287	€1.9m	-22.9%	no data
1.27%	Two Sigma Advisers, LP	2,527,000	€1.8m	-30.1%	no data
1.06%	Citadel Advisors LLC	2,091,105	€1.5m	19.2%	no data
0.91%	JPMorgan Chase & Co, Brokerage and Securities Investments	1,808,240	€1.3m	68.5%	no data
0.78%	Northern Trust Global Investments	1,539,008	€1.1m	-0.07%	no data
0.77%	Bank of America Corporation, Asset Management Arm	1,518,138	€1.1m	-6.31%	no data
0.76%	Woodline Partners LP	1,503,754	€1.1m	0%	0.01%
0.72%	Goldman Sachs Group, Investment Banking and Securities Investments	1,435,194	€1.0m	-45.6%	no data
0.61%	Wells Fargo & Company, Private Banking and Investment Banking Arm	1,213,896	€865.9k	1,060%	no data
0.54%	Rhenman & Partners Asset Management AB	1,066,495	€760.8k	-44.3%	0.08%
0.48%	Millennium Management LLC	961,035	€685.6k	15.8%	no data
0.44%	Squarepoint OPS LLC	877,408	€625.9k	159%	no data
0.42%	Kieger AG	842,060	€600.7k	0%	0.22%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/19 11:56
End of Day Share Price	2025/05/19 00:00
Earnings	2025/03/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Esperion Therapeutics, Inc. is covered by 17 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Jason Zemansky	BofA Global Research
Kristen Kluska	Cantor Fitzgerald & Co.
Jason Butler	Citizens JMP Securities, LLC